Authors: Bohao Liu, Bryan Wang, Xiaokan Zhang, Roberta Lock, Trevor Nash, Gordana Vunjak-Novakovic
Published: 2021-02-10
DOI: 10.1126/scitranslmed.abd0914
Source: Full article
microRNA-based therapies for myocardial infarction have opportunities and limitations on the basis of the target cell type and molecular pathways.